Unilateral vestibular schwannoma in a patient with schwannomatosis in the absence of LZTR1 mutation
- PMID: 26848914
- PMCID: PMC5088062
- DOI: 10.3171/2015.11.JNS151766
Unilateral vestibular schwannoma in a patient with schwannomatosis in the absence of LZTR1 mutation
Abstract
The presence of vestibular schwannomas has long been considered an exclusion criterion for the diagnosis of schwannomatosis. Recently, 2 cases of vestibular schwannoma were reported in patients with schwannomatosis, leading to a revision of the diagnostic criteria for this genetic disorder. Overall, the relative infrequency of vestibular schwannomas in schwannomatosis is unexplained, and the genetics of this uncommon phenomenon have not been described. The authors report on a family with clinical manifestations consistent with schwannomatosis, including 4 affected members, that was identified as having an affected member harboring a unilateral cerebellopontine angle mass with extension into the internal auditory canal. Radiologically, this mass was consistent with a vestibular schwannoma and resulted in a symptomatic change in ipsilateral hearing (word recognition 86% at 52 dB) and increased latency of the wave I-V interval on auditory brainstem response testing. The patient was found to be negative for a germline mutation of NF2 and LZTR1, and her affected mother was found to harbor neither NF2 nor SMARCB1 mutations on genetic testing. Although vestibular schwannomas have been classically considered to not occur in the setting of schwannomatosis, this patient with schwannomatosis and a vestibular schwannoma further confirms that schwannomas can occur on the vestibular nerve in this syndrome. Further, this is the first such case found to be negative for a mutation on the LZTR1 gene.
Keywords: LZTR1; NF2 = neurofibromatosis Type 2; cranial nerve; schwannomatosis; vestibular schwannoma.
Conflict of interest statement
The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.
Figures


Similar articles
-
The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis.Hum Genet. 2017 Feb;136(2):129-148. doi: 10.1007/s00439-016-1753-8. Epub 2016 Dec 5. Hum Genet. 2017. PMID: 27921248 Free PMC article. Review.
-
Mutations in LZTR1 add to the complex heterogeneity of schwannomatosis.Neurology. 2015 Jan 13;84(2):141-7. doi: 10.1212/WNL.0000000000001129. Epub 2014 Dec 5. Neurology. 2015. PMID: 25480913 Free PMC article.
-
Revisiting neurofibromatosis type 2 diagnostic criteria to exclude LZTR1-related schwannomatosis.Neurology. 2017 Jan 3;88(1):87-92. doi: 10.1212/WNL.0000000000003418. Epub 2016 Nov 16. Neurology. 2017. PMID: 27856782 Free PMC article.
-
Coexistence of schwannomatosis and glioblastoma in two families.Eur J Med Genet. 2019 Aug;62(8):103680. doi: 10.1016/j.ejmg.2019.103680. Epub 2019 May 22. Eur J Med Genet. 2019. PMID: 31128261
-
Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 2 and Related Disorders.Clin Cancer Res. 2017 Jun 15;23(12):e54-e61. doi: 10.1158/1078-0432.CCR-17-0590. Clin Cancer Res. 2017. PMID: 28620005 Review.
Cited by
-
The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis.Hum Genet. 2017 Feb;136(2):129-148. doi: 10.1007/s00439-016-1753-8. Epub 2016 Dec 5. Hum Genet. 2017. PMID: 27921248 Free PMC article. Review.
-
Classification of schwannomas and the new naming convention for "neurofibromatosis-2": Genetic updates and international consensus recommendation.Neuroradiol J. 2025 Jan 9:19714009251313510. doi: 10.1177/19714009251313510. Online ahead of print. Neuroradiol J. 2025. PMID: 39786185 Free PMC article. Review.
-
Phenotypic and genotypic overlap between mosaic NF2 and schwannomatosis in patients with multiple non-intradermal schwannomas.Hum Genet. 2018 Jul;137(6-7):543-552. doi: 10.1007/s00439-018-1909-9. Epub 2018 Jul 13. Hum Genet. 2018. PMID: 30006736 Clinical Trial.
-
Hearing loss and vestibular schwannoma: new insights into Schwann cells implication.Cell Death Dis. 2023 Sep 23;14(9):629. doi: 10.1038/s41419-023-06141-z. Cell Death Dis. 2023. PMID: 37741837 Free PMC article. Review.
-
Vestibular Schwannoma: What We Know and Where We are Heading.Head Neck Pathol. 2020 Dec;14(4):1058-1066. doi: 10.1007/s12105-020-01155-x. Epub 2020 Mar 30. Head Neck Pathol. 2020. PMID: 32232723 Free PMC article. Review.
References
-
- Boyd C, Smith MJ, Kluwe L, Balogh A, Maccollin M, Plotkin SR. Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis. Clin Genet. 2008;74:358–366. - PubMed
-
- Evans DG, Huson SM, Donnai D, Neary W, Blair V, Newton V, et al. A clinical study of type 2 neurofibromatosis. Q J Med. 1992;84:603–618. - PubMed
-
- MacCollin M, Chiocca EA, Evans DG, Friedman JM, Horvitz R, Jaramillo D, et al. Diagnostic criteria for schwannomatosis. Neurology. 2005;64:1838–1845. - PubMed
-
- Melean G, Sestini R, Ammannati F, Papi L. Genetic insights into familial tumors of the nervous system. Am J Med Genet C Semin Med Genet. 2004;129C:74–84. - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous